| # | Drug | Count |
|---|---|---|
| 0 | AXICABTAGENE CILOLEUCEL | 107 |
| 1 | CILTACABTAGENE AUTOLEUCEL | 43 |
| 2 | LISOCABTAGENE MARALEUCEL | 25 |
| 3 | BREXUCABTAGENE AUTOLEUCEL | 22 |
| 4 | IBRUTINIB | 19 |
| 5 | IDECABTAGENE VICLEUCEL | 13 |
| 6 | CYCLOPHOSPHAMIDE | 12 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 12 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 12 |
| 9 | TOCILIZUMAB | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LISOCABTAGENE MARALEUCEL | 25 | 0.0285 |
| 1 | AXICABTAGENE CILOLEUCEL | 107 | 0.0105 |
| 2 | IDECABTAGENE VICLEUCEL | 13 | 0.0105 |
| 3 | BREXUCABTAGENE AUTOLEUCEL | 22 | 0.0102 |
| 4 | CILTACABTAGENE AUTOLEUCEL | 43 | 0.0065 |
| 5 | REVUMENIB | 2 | 0.0019 |
| 6 | SILTUXIMAB | 1 | 0.0015 |
| 7 | FILGRASTIM-AAFI | 1 | 0.0015 |
| 8 | ATROPINE INJECTION, 2 MG | 2 | 0.0013 |
| 9 | FAMCICLOVIR | 3 | 0.0011 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD19-directed Chimeric Antigen Receptor [EPC] | 107 | 0.0105 |
| 1 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Sulfone [EPC] | 4 | 0.0004 |
| 3 | Interleukin-1 Receptor Antagonist [EPC] | 4 | 0.0002 |
| 4 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 5 | BCL-2 Inhibitor [EPC] | 9 | 0.0001 |
| 6 | General Anesthetic [EPC] | 6 | 0.0001 |
| 7 | Anticholinergic [EPC] | 2 | 0.0001 |
| 8 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 12 | 0.0001 |
| 9 | Phenothiazine [EPC] | 3 | 0.0001 |